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Abstract. Critical parameters affecting the stereoselective amination of (hetero)aromatic ketones 
using transaminases have been studied such as temperature, pH, substrate concentration, co-
solvent and source and percentage of amino donor, to further optimize the production of 
enantiopure amines using both (S)- and (R)-selective biocatalysts from commercial suppliers. 
Interesting enantiopure amino building blocks have been obtained overcoming some limitations 
of traditional chemical synthetic methods. Representative processes were scaled-up affording 
halogenated and heteroaromatic amines in enantiomerically pure form and good isolated yields. 
1. Introduction 
The synthesis of enantiopure amines is highly demanded due to the broad spectrum of 
biological activities that they display, but also due to their application as chiral building blocks 
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for the synthesis of more complex structures.
1
 For instance, ortho- and meta-halogenated 
aromatic derivatives are intermediates of potent potassium channel openers (Figure 1a),
2
 
modulators of hypertension (Figure 1b),
3
 calcimimetic agents to treat hyperparathyroidism 
(Figure 1c),
4
 or anti-arthritic drugs.
5
 Unfortunately, synthetic routes towards these compounds 
still remain challenging. Apart from the kinetic resolutions
6
 of the racemic amines, where the 
maximum yield of the enantiopure product is 50%, some interesting examples involving 
sequential reactions
7
 have recently been developed, but either the isolated yields or the 
selectivities were not completely satisfactory. A highly efficient system based on the ruthenium-
catalyzed hydrogen transfer over sulfinylimines has also been described, obtaining excellent ee 
(98%) for the meta-chloro substituted compound, but ee decreased (91%) for the ortho 
derivative.
8
 
 
 
Figure 1. Examples of biologically active or natural compounds where halogenated aromatic or 
heteroaromatic chiral amines are key building blocks. 
 
Another family of valuable amines includes those possessing a heteroaromatic ring close to the 
chiral amino group. Pyridine derivatives can be used as potential ligands or as acyl-transfer 
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catalysts to induce chirality.
9
 Moreover, they have also been studied as building blocks for non-
steroidal agents in the treatment of prostatic cancer.
10
 On the other hand, the chiral 1-(thiazol-2-
yl)ethylamine fragment is also present in natural compounds such as dysidenin (Figure 1d).
11
 
The selective synthesis of these amines has also proved to be difficult, and although several 
multi-step synthetic routes
11,12
 and lipase-catalyzed resolutions of the corresponding racemates 
have been reported,
13
 no general and straightforward methodologies for these chiral building 
blocks have been described yet. 
-Transaminases (-TAs, EC 2.6.1.x) have been extensively studied during the last few years 
for the synthesis of chiral amines, displaying excellent stereoselectivities under mild reaction 
conditions.
1a,14
 Nevertheless, the application of -TAs to synthesize the target chiral amines 2b-
p (Scheme 1) has been scarcely developed.
15
 Herein, several reaction parameters that affect the 
reductive amination processes of the commercially available ketone precursors for these amines 
were optimized, focusing on the substrate concentration for further scaling-up purposes. 
 
2. Results and Discussion 
In a first set of experiments, a screening kit of 24 commercially available transaminases was 
employed with acetophenone (1a, 25 mM) as a model substrate. The reactions were performed in 
phosphate buffer 100 mM pH 8 supplemented with pyridoxal phosphate (PLP, 0.25 mM) and 
isopropylamine (1 M)
16
 or L- or D-alanine (50 mM) coupled with lactate dehydrogenase, glucose 
and glucose dehydrogenase to recycle the catalytic amount of the nicotinamide cofactor added in 
the medium,
17
 thus shifting the thermodynamic equilibrium towards the desired amine formation. 
After this enzymatic screening (see Table S1 in the Supporting Information for further details), 
two (S)-selective, namely TA-P1-A06 and TA-P1-G06, and two (R)-selective transaminases, 
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namely ATA-025 and ATA-033, were chosen for further studies due to their highest activities 
(up to 54% conversion) and excellent selectivities (>99% ee). All four biocatalysts worked well 
under the very convenient isopropylamine approach, the last two transaminases being especially 
relevant since, apart from a few recent examples, not many ω-TAs have been found to display 
the (R)-stereopreference.
18
 Having selected the adequate biocatalysts, the reaction conditions 
were studied to optimize the transamination process using ketones 1b-p as starting materials 
(Scheme 1). 
 
Scheme 1. Transaminase-catalyzed synthesis of enantiopure amines (R)- or (S)-2a-p. 
 
 
The influence of an organic solvent applied to enzymatic transformations has previously been 
discussed in depth.
19
 In the case of transaminases, although less developed, various examples 
recently showed that the use of an organic co-solvent can improve the enzymatic 
performance.
15f,18c,20
 Thus, several solvents such as MeOH, EtOH, 
i
PrOH, CH3CN, 
tetrahydrofuran (THF) or dimethylsulfoxide (DMSO) were added at 2.5% v/v in the 
transformation of p-chloroacetophenone (1c) with ATA-033, demonstrating that their use was 
indeed beneficial, achieving higher activities with DMSO than when compared to the sole buffer 
as reaction medium (see Table S2 in the SI). Next, different proportions of DMSO were tested 
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without any further improvement (see Table S3 in the SI), therefore 2.5% v/v was selected as the 
optimum amount for subsequent reactions. 
The pH profile of these transformations was also explored using m-bromoacetophenone (1g) as 
model substrate with ATA-025 and ATA-033, finding that a pH at around 7.5 was the most 
appropriate for the production of enantiopure (R)-2g, with up to 86% conversion (see Table S4 in 
the SI). A temperature study of the process was also performed and showed that 30 ºC was the 
optimum temperature for these reactions (see Table S5 in the SI). Finally, another amino donor, 
n-butylamine, was tested to replace isopropylamine with these biocatalysts, but only negligible 
conversions were achieved (see Table S6 in the SI). 
Having in hand the best reaction conditions, ketones 1a-p were transformed with these four 
transaminases obtaining the following results shown in Table 1. In the case of the halogenated 
derivatives, when compared with acetophenone (1a, entry 1), para-substituted compounds 1b-d 
did not deter the enzymatic activity, obtaining slightly better results with the chlorinated and 
brominated ketones (entries 3 and 4) than with the fluorinated one (entry 2). This tendency was 
confirmed for the meta-halogenated derivatives 1e-g, although higher conversions (60-85%) 
were achieved (entries 5-7). Surprisingly, sterically hindered ortho-substituted ketones 1h-j 
(entries 8-10) afforded excellent conversions (>90%), in contrast to the results obtained with 
previous methodologies. 2-Fluoroacetophenone (1h) showed especially high conversions with all 
four biocatalysts, while chlorinated (1i) and brominated (1j) acetophenones were too bulky for 
the (S)-selective TAs, but not for the (R)-selective, obtaining quantitative conversions in this 
case. Pleasingly, all the amines were obtained with excellent ee (>97%). 
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Figure 2. Positive influence of the halogen atom at ortho position in the TA-catalyzed reactions 
of 1h (red bars) vs 1a (blue bars) using 1 M (dark color) or 100 mM (light color) concentration 
of isopropylamine as amino donor. 
 
These excellent (and unexpected) results towards the formation of the ortho-aromatic amines 
suggested that another effect could be present. Recently, Mutti and Kroutil have described a 
positive influence in the TA-catalyzed reactions over -keto esters and -oxygenated ketones 
due to the establishment of a likely intramolecular H-bond between the formed amine and the 
oxygen atom,
20b
 therefore stabilizing the final compound and driving the transamination more 
easily. In our case, the formation of a stabilizing interaction between the amine and the halogen 
atom at the ortho-position could also be possible.
21
 In order to demonstrate this effect, -TA-
catalyzed reactions with acetophenone (1a) and ortho-fluoroacetophenone (1h) were performed 
separately with all four enzymes in the presence of a lower concentration of isopropylamine (100 
mM) as amino donor, only a 4-fold excess with respect to the ketone substrate. As can be seen in 
Figure 2, while conversions for 1a decreased from around 60% to less than 20% (3-fold), in the 
0
10
20
30
40
50
60
70
80
90
100
c
(%
)
TA-P1-A06 TA-P1-G06 ATA-025 ATA-033
 7 
case of 1h conversions declined from 95% to 65% (1.5-fold), demonstrating a more favored 
process in the case of this ketone. 
 
Table 1. Enzymatic asymmetric amination of ketones 1a-p using -TAs and 
isopropylamine.
a
 
entry ketone TA-P1-A06 TA-P1-G06 ATA-025 ATA-033 
  c (%)
b
 ee (%)
c
 c (%)
b
 ee (%)
c
 c (%)
b
 ee (%)
c
 c (%)
b
 ee (%)
c
 
1 1a 58 99 (S) 65 99 (S) 62 99 (R) 61 99 (R) 
2 1b 43 >99 (S) 43 >99 (S) 45 >99 (R) 43 >99 (R) 
3 1c 53 98 (S) 58 >99 (S) 67 >99 (R) 60 >99 (R) 
4 1d 52 >99 (S) 56 >99 (S) 63 99 (R) 58 98 (R) 
5 1e 63 >99 (S) 63 >99 (S) 70 >99 (R) 71 >99 (R) 
6 1f 70 >99 (S) 70 >99 (S) 74 >99 (R) 76 >99 (R) 
7 1g 78 >99 (S) 73 >99 (S) 84 >99 (R) 86 >99 (R) 
8 1h 93 >99 (S) 94 >99 (S) 95 >99 (R) 94 99 (R) 
9 1i 64 98 (S) 48 99 (S) 98 >99 (R) 98 >99 (R) 
10 1j 27 99 (S) 11 93 (S) 99 >99 (R) 99 >99 (R) 
11 1k 83 >99 (S) 98 >99 (S) 99 >99 (R) 98 >99 (R) 
12 1l <1 n.d. <1 n.d. <1 n.d. <1 n.d. 
13 1m 87 89 (S) 93 90 (S) 83 87 (R) 89 88 (R) 
14
d
 1n 41 >99 (S) 29 98 (S) 44 >99 (R) 42 96 (R) 
15 1o 92 >99 (S) 92 >99 (S) 93 >99 (R) 92 >99 (R) 
16
d
 1p 79 98 (S) 76 99 (S) 80 >99 (R) 83 >99 (R) 
a
 Reaction conditions: Ketone 1a-p (25 mM) in phosphate buffer 100 mM pH 7.5 with 
PLP (0.25 mM), TA (2 mg), DMSO (2.5% v/v), and isopropylamine (1 M) for 24 h at 30 
ºC and 250 rpm. 
b
 Measured by GC. 
c
 Measured by chiral GC or HPLC. 
d
 Formation of 2-
3% of a by-product. 
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We also exploited this effect to perform the successful transamination of the ortho,ortho-
difluorinated ketone 1k (entry 11) with complete conversions using three different enzymes, 
while unfortunately the dichlorinated substrate 1l (entry 12) was already too bulky for these TAs. 
Additionally, a series of heterocyclic ketones (1m-p) were tested with the four best 
transaminases to study the influence of a nitrogen atom in the aromatic ring, and then a 5-
membered heteroaromatic ring such as thiazole. For the pyridinic compounds, when the nitrogen 
atom was at the 4- (1m, entry 13) or 2-position (1o, entry 15), conversions were excellent, 
although selectivity decreased for substrate 1m. In the case of derivative 1n, a much lower 
conversion was achieved (29-44%, entry 14). In the case of the thiazole-derived ketone 1p, high 
conversions (76-83%) of the enantioenriched amine were obtained (>97% ee, entry 16). 
Several selected transamination reactions were scaled-up to 200 mg with the corresponding 
ketone at a 100 mM substrate concentration (Table 2), obtaining high to excellent conversions 
and complete selectivities with the ortho-halogenated ketones 1h-j (entries 2-4), while moderate 
to high conversions were achieved with 1g and 1p (entries 1 and 5). Furthermore, additional 
experiments were performed at higher substrate concentration (250 mM) at a 250 mg-scale using 
only a tenth of the enzyme loading (20 mg), obtaining conversions higher than 85% into 
enantiopure brominated amine (R)-2j after 48 h employing ATA-025 and ATA-033 (entries 6 
and 7). 
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Table 2. Scale-up in the transamination reactions of amines 1g-j,p.
a
 
entry ketone enzyme
b 
scale (mg) 1g-j,p (mM) time (h) c (%)
c
 ee (%)
d
 
1 1g TA-P1-A06 (100 mg) 200 100 24 74 99 (S) 
2 1h TA-P1-G06 (100 mg) 200 100 24 87 >99 (S) 
3 1i ATA-025 (100 mg) 200 100 24 96 >99 (R) 
4 1j ATA-033 (100 mg) 200 100 24 95 >99 (R) 
5 1p TA-P1-G06 (100 mg) 200 100 24 59 >99 (S) 
6 1j ATA-025 (20 mg) 250 250 48 85 >99 (R) 
7 1j ATA-033 (20 mg) 250 250 48 89 >99 (R) 
a
 Reaction conditions: Ketone 1g-j,p in phosphate buffer 100 mM pH 7.5 with PLP (0.25 mM), 
TA, DMSO (2.5% v/v), and isopropylamine (1 M) at 30 ºC and 250 rpm. 
b
 Source and loading of 
enzyme for the transformation. 
c
 Measured by GC. 
d
 Measured by chiral GC or HPLC. 
 
Finally, in order to demonstrate the applicability of the process at a much higher scale, 1 g of 
ketones 1g-j were subjected to biocatalytic transamination at a 100 mM substrate concentration, 
obtaining similar conversions to those achieved with 200 mg of substrate and recovering the 
enantiopure amines with high isolated yields after a simple extraction protocol (Figure 3). 
 
Figure 3. Results from the biocatalytic transamination of selected ketones at 1 g-scale and 100 
mM substrate concentration. 
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3. Conclusions 
In summary, we have demonstrated the use of transaminases as a potent tool applied for the 
synthesis of a series of enantiopure amines whose chemical routes were previously based on 
multi-step protocols or did not afford the final targets with satisfactory selectivities. After a 
careful review of the literature, we have found that described chemo- or enzymatic methods 
allow the production of (S)-2g in >99% ee and 47% isolated yield through lipase-catalyzed 
resolution of the racemic amine,
6b
 or alternatively in 62% yield with 71% ee under 
organocatalytic transamination.
7a
 Also under these conditions (S)-2h could be synthesized with a 
65% isolated yield and 84% ee,
7a
 while employing a sequential amination-hydrogenolysis 
protocol, it was obtained in 44% yield and 98% ee.
7b
 Amine (R)-2i was isolated through 
asymmetric transfer hydrogenation of a sulfonylimine precursor with 96% yield and 91% ee.
8a
 
On the other hand, there is just one example described by Truppo and co-workers where (R)-2j 
was synthesized via transaminase-catalyzed reaction in a 50% isolated yield with >98% ee.
15f
 
Herein, starting from easily available ketones and after optimization of the enzymatic reaction 
conditions, it has been demonstrated that several commercially available TAs can be employed 
to obtain various halogenated and heterocyclic amines. Efforts have been focused on the 
optimization of the scale-up of the biocatalytic transamination and the substrate concentration, so 
taking into account other TA-catalyzed protocols, the transformations were successfully carried 
out at higher concentrations between 100-250 mM (14-50 g/L), affording in all cases the 
enantiopure amines with high isolated yields. Thus, this optimization study clearly offers a new 
advantageous alternative in terms of production and economic issues towards derivatives which 
are not easily accessible. 
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Experimental Section 
General. Ketones 1a-p and amines 2a,d,m-o were purchased from commercial sources and 
used as received. Codex
®
 Transaminase Screening Kit (ATASK-000250), PLP, lactate 
dehydrogenase and glucose dehydrogenase present in the PRM-102 mix were purchased from 
Codexis. All other reagents and solvents were of the highest purity available. 
Chemical reactions were monitored by analytical TLC, performed on silica gel 60 F254 plates 
and visualized by UV. Flash chromatography was performed using silica gel 60 (230-400 mesh). 
IR spectra were recorded on an infrared Fourier transform spectrophotometer on NaCl pellets. 
NMR spectra were recorded at 300 (
1
H), and 75 (
13C) MHz. The chemical shifts (δ) are reported 
in parts per million (ppm) relative to the solvent residual signals and the coupling constants (J) in 
Hertz (Hz). ESI-TOF mode was used to record high resolution mass spectra (HRMS). Gas 
chromatography (GC) analyses were performed on a standard gas chromatograph equipped with 
a FID. HPLC analyses were performed using a standard HPLC chromatograph with UV 
detection. Optical rotations were measured using a standard polarimeter with a sodium lamp (D) 
and are reported in units of 10
-1
 deg cm
2
 g
-1
. 
General protocol for the TA-catalyzed amination of ketones 1a-p. In a 1.5 mL Eppendorf 
tube, 1a-p (25 mM) was dissolved in DMSO (12 µL, 2.5% v/v) and phosphate buffer 100 mM 
pH 7.5 (485 µL, 0.25 mM PLP, 1 M isopropylamine) and the corresponding transaminase (2 mg) 
were added. The reaction was shaken at 30 ºC and 250 rpm for 24 h and stopped by addition of 
10 N NaOH (400 µL). Then the mixture was extracted with ethyl acetate (2  500 µL), the 
organic layers were separated by centrifugation (90 sec, 13000 rpm), combined and finally dried 
over Na2SO4. Conversions of 2a-p were determined by GC. In most cases, acetylation of the 
sample was necessary to measure ee. For results, see Table 1 in the manuscript. 
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Scale-up of the transamination reactions. In a 250 mL Erlenmeyer flask, 1g-j (1 g, 100 mM) 
was dissolved in DMSO (2.5% v/v) and phosphate buffer 100 mM pH 7.5 (0.25 mM PLP, 1 M 
isopropylamine) and the corresponding transaminase (400 mg) were added. The reaction was 
shaken at 30 ºC and 250 rpm for 24 h and stopped by addition of 6 N HCl until acid pH is 
achieved. Before that, a 200 µL aliquot was taken and treated as previously described to measure 
conversion and enantiomeric excess of the product. Then, the reaction mixture was filtered and 
the unreacted ketone and DMSO separated by continuous extraction using CH2Cl2 (80 mL) for 
72 h. Next, the aqueous phase was basified until pH 10 with NaOH pellets and extracted with 
CH2Cl2 (3 × 50 mL). Organic phases were combined, dried over Na2SO4, and the solvent 
evaporated under reduced pressure to finally obtain the pure amine. Isolated yields: 62% (2g), 
61% (2h), 80% (2i) and 76% (2j). 
 
Supporting Information. Experimental procedures for the chemical synthesis of racemic 
amines and the biocatalytic transamination experiments, full characterization of novel 
compounds, spectroscopic and analytical data of the enantioenriched final products are included. 
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